In the validation sample, higher plasma S1P levels were independent predictors of GCC, and plasma S1P levels demonstrated an AUC of 0.738 (95% CI: 0.599–0.849) to differentiate patients with GCC from PCC. This evidence concerns the gene MBTPS1 and goblet cell carcinoma.